Jul. 13, 2012 at 9:05am

Glaxo Smith Kline, or #GSK, recently agreed to pay $3 Billion Dollars in a record setting investigation by the Department of Justice (DOJ). The settlement centered around a number of questionable, and allegedly illegal business practices, in the promotion of a number of pharmaceutical products. This was an Exhibit in the DOJ investigation.

Mother Jones posted the video and the article below which appears in full context here.

Cruises, Pheasant Hunting Trips, and Political Donations: The 5 Skeeziest GlaxoSmithKline Perks Revealed

—By Sydney Brownstone

(Source: recallattorneys.com)

Jul. 3, 2012 at 8:53am

Glaxo GSK Avandia Paxil Wellbutrin FDA US Food Drug Administration off label promotion

“

GlaxoSmithKline, the maker of the popular depression drugs Paxil and Wellbutrin, agreed to plead guilty to federal charges and pay $3 billion in the largest healthcare-fraud settlement in U.S. history.

—

GlaxoSmithKline settles drug-marketing case for $3 billion

In a record setting fine, $3B, Glaxo has agreed to pay over allegations of over promoting drugs for use not approved by the FDA. This sweeping settlement includes claims over Avandia, Paxil & Wellbutrin. It also involves allegations of youth marketing and targeting of under age children for uses not approved by the FDA.